Driven by a pursuit of innovation on behalf of the patients we serve, Sumitomo Pharma America, Inc. (SMPA) delivers needed products and accelerates drug development in key areas of unique and unmet medical need for people worldwide. Across multiple therapeutic areas and clinical research programs, including oncology, women’s health, urology, rare disease, neurology & psychiatry and cell & gene therapies, we operate with scientific rigor, compassion and determination to bring needed therapies to patients sooner, and to deliver better experiences for patients and caregivers on the things that matter most to them.